Norman N. Chan
About
In The Last Decade
Norman N. Chan
13 papers receiving 842 citations
Peers
Comparison fields: 5 of 87
- Endocrinology, Diabetes and Metabolism 368
- Epidemiology 271
- Nephrology 248
- Cardiology and Cardiovascular Medicine 183
- Oncology 148
Countries citing papers authored by Norman N. Chan
This map shows the geographic impact of Norman N. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman N. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman N. Chan more than expected).
Fields of papers citing papers by Norman N. Chan
This network shows the impact of papers produced by Norman N. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman N. Chan. The network helps show where Norman N. Chan may publish in the future.
Co-authorship network of co-authors of Norman N. Chan
This figure shows the co-authorship network connecting the top 25 collaborators of Norman N. Chan. A scholar is included among the top collaborators of Norman N. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman N. Chan. Norman N. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 0 | |
| 3 | 166 | |
| 4 | 54 | |
| 5 | 92 | |
| 6 | 42 | |
| 7 | Metabolic syndrome and type 2 diabetes: the Hong Kong perspective. | 11 |
| 8 | 27 | |
| 9 | The metabolic effects of insulin and rosiglitazone combination therapy in Chinese type 2 diabetic patients with nephropathy. | 3 |
| 10 | 185 | |
| 11 | 116 | |
| 12 | 52 | |
| 13 | 96 | |
| 14 | Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.